Researchers used a validated questionnaire to screen 2,590 obese patients admitted to a hospital for internal medicine, family medicine or cardiology services for disordered breathing. They found that patients with a high risk of sleep apnea experienced a rapid response event more frequently (43.06 per 1,000 admissions) than low-risk patients (25.91 per 1,000 admissions).
Then, when high-risk patients were compliant with positive airway pressure treatment, they had less rapid response events (16.99 per 1,000 admissions) than those who were noncompliant (53.40 per 1,000 admissions).
“The study suggests the important role of treating underlying sleep apnea to improve patient safety and quality in the hospital,” said Sunil Sharma, MD, pulmonologist with Jefferson Sleep Disorder Center in Philadelphia. “We recommend a multi-centric prospective study to confirm these findings and determine the cost benefit of such [an] initiative to improve hospital patient safety.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
